Investor insights
Sectors invested in
Funding rounds participated in
$68M sweet spot round size
Most of their 31 investments are in rounds between $30M and $105M
Investor type
Basic info
Industry
Sectors
Date founded
2017
Investments made
Beta Bionics raised $100M on August 30, 2023
Investors: Sands Capital Management, Farallon Capital Management, Pura Vida Investments, Perceptive Advisors, Marshall Wace, RTW Investments, LP, Soleus Capital Management, L.P., Eventide Asset Management, Omega Funds and LifeSci Venture Partners
Undisclosed raised $150M on May 10, 2022
Investors: Nextech Invest, The Invus Group, Section 32, Third Rock Ventures, Goldman Sachs Asset Management and LifeSci Venture Partners
Beta Bionics raised $57M on February 17, 2022
Investors: Soleus Capital Management, L.P., Pura Vida Investments, Novo Nordisk Ltd, Eventide Asset Management, RTW Investments, LP, Farallon Capital Management, Perceptive Advisors and LifeSci Venture Partners
Ceptur Therapeutics raised $75M on January 19, 2022
Investors: Perceptive Advisors, venBio Partners, Qiming Venture Partners, Bristol-Myers Squibb, UK, Affinity Asset Advisors and LifeSci Venture Partners
Antios Therapeutics raised $75M on November 3, 2021
Investors: GRA Venture Fund LLC, Sixty Degree Capital, GordonMD Global Investments LP, RA Capital Management, L.P., Lumira Ventures, Pontifax Venture Capital, Soleus Capital Management, L.P. and LifeSci Venture Partners
Clade Therapeutics raised $87M on November 3, 2021
Investors: Bristol-Myers Squibb, UK, Emerson Collective, Syncona Limited and LifeSci Venture Partners
Antios Therapeutics raised $96M on April 12, 2021
Investors: Sixty Degree Capital, Soleus Capital Management, L.P., Domain Associates, Pontifax Venture Capital, Lumira Ventures, RA Capital Management, L.P. and LifeSci Venture Partners
Pyxis Oncology raised $152M on March 30, 2021
Investors: Leaps by Bayer, Tekla Capital Management, Logos Global Management, LP, RTW Investments, LP, Surveyor Capital, Ridgeback Capital Management LLC, Perceptive Advisors, Longwood Fund and LifeSci Venture Partners
Omega Therapeutics raised $126M on March 30, 2021
Investors: Point72 Asset Management, The Invus Group, Flagship Ventures, Logos Global Management, LP and LifeSci Venture Partners
Undisclosed raised $24M on March 16, 2021
Investors: ATEM Capital, Longley Capital, -, Pritzker Vlock Family Office, JSR Corporation, Validus Growth Investors, LLC and LifeSci Venture Partners